GrowthEHFPNCT01825226
Helen Keller International's Enhanced-Homestead Food Production Program in Burkina Faso
A study testing Enhanced-Homestead Food Production Program in people with Growth and Anemia, run by International Food Policy Research Institute at 1 site in United States.
Trial summary
Helen Keller International (HKI) has been implementing homestead food production (HFP) programs in Asia for the past 20 years and has recently begun implementing HFP programs in Africa as well. Read more about this study
- Who is it for?
- Ages 3 to 12 months
- What is being tested?
- Enhanced-Homestead Food Production Program
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 1,763 participants
- Where
- 1 siteUnited States
- Study dates
- Feb 2010to 28 Sep 2016
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 3 to 12 months
- All sexes
- No healthy volunteers
- Child
Who may be able to join
- Mother of child between the ages of 3 and 12 months and her child
Who cannot join
- N/A
Trial locations and contacts
1 site in 1 country.
United States1 site
International Food Policy Research Institute
Washington D.C., District of Columbia, 20006
About this study
Official title: THE IMPACT OF THE ENHANCED HOMESTEAD FOOD PRODUCTION PROGRAM ON CHILD HEALTH
Helen Keller International (HKI) has been implementing homestead food production (HFP) programs in Asia for the past 20 years and has recently begun implementing HFP programs in Africa as well. In general, these programs target women and are designed to improve maternal and child health and nutrition outcomes through three primary pathways: 1. Increasing the availability of micronutrient-rich foods through increased household production of these foods; 2. Raising income through the sale of surplus production; and 3. Increasing knowledge and adoption of optimal nutrition practices, including the consumption of micronutrient-rich foods. Evaluations of HFP programs have consistently demonstrated significant increases in household production and consumption of micronutrient-rich foods. This increased consumption, along with improvements in health and nutrition related knowledge, and increased income, could all contribute to improvements in maternal and child health and nutrition outcomes. However, to date there has been limited understanding as to how these types of programs can be optimized to maximize impacts on these outcomes.
In order to better understand the potential of these types of programs to improve maternal and child health and nutrition outcomes and how this impact may be achieved IFPRI has been collaborating with HKI to evaluate one of their E-HFP programs in Burkina Faso. The evaluation considers impact of the program through the three pathways above, and assesses anthropometric and clinical measures of nutrition, as well as looking at how the programs might be improved.
- Being tested
- Enhanced-Homestead Food Production Program
- Medical subject headings
- Anemia
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Enhanced-Homestead Food Production ProgramOther
Participation in an enhanced-homestead food production program including home gardening and nutrition and health behavior change communication
| Study group | Role | What they receive |
|---|---|---|
| Program participation | Experimental | Participation in an enhanced-homestead food production program including home gardening and nutrition and health behavior change communication Receives: Other: Enhanced-Homestead Food Production Program |
| Control | No intervention | Not described |
What is being measured
The primary outcome is the main question the study is designed to answer.
Growth
Change in height-for-age Z-scores, weight-for-age Z-scores and weight-for-height Z-scores will be measured as well as the change in the prevalence of stunting (HAZ <-2), underweight (WAZ <-2) and wasting (WHZ <-2) over the course of the two year program period.
Measured: Measurements will be made for children between the ages of 3 and 12 months of age at baseline and then 2 years later, at endline, when the children are between the ages of 23 and 40 months
Hemoglobin
Measured: Measurements will be made for children between the ages of 3 and 12 months of age at baseline and then 2 years later, at endline, when the children are between the ages of 23 and 40 months
Secondary outcomes (8)
Food security
Measured: Baseline (2010), Endline (2012), follow-up (2013)
Household assets
Measured: Baseline (2010), Endline (2012), follow-up (2013)
Household consumption
Measured: Baseline (2010), Endline (2012), follow-up (2013)
Household livestock holdings
Measured: Baseline (2010), Endline (2012), follow-up (2013)
Dietary diversity
Measured: Baseline (2010), Endline (2012), follow-up (2013)
Mother's BMI
Measured: Baseline (2010), Endline (2012), follow-up (2013)
Maternal health and nutrition-related knowledge
Measured: Baseline (2010), Endline (2012), follow-up (2013)
IYCF practices
Measured: Baseline (2010), Endline (2012), follow-up (2013)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted5 Apr 2013 (estimated)
- Study startFeb 2010
- Primary completionJun 2013
- Study completion28 Sep 2016
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (3)Papers the sponsor has linked to this study.
- Other trials for GrowthStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 1,763 participants (actual)
Sponsor and investigators
- Lead sponsor
- International Food Policy Research Institute
- Sponsor type
- University, hospital or other
- Collaborators
- United States Agency for International Development (USAID), Bill and Melinda Gates Foundation
- Responsible party
- Sponsor
- Investigators
- Deanna K Olney, Ph.D., Principal investigator, International Food Policy Research InstituteAndrew Dillon, Ph.D., Principal investigator, Michigan Sate University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01825226
- Sponsor's protocol ID
- 6117001
- Acronym
- EHFP
- Status last verified
- Apr 2025
- First submitted
- 1 Jan 2013
- Last updated
- 1 May 2025
- Results posted
- No
- Data monitoring committee
- No
Publications
Nielsen JN, Olney DK, Ouedraogo M, Pedehombga A, Rouamba H, Yago-Wienne F. Process evaluation improves delivery of a nutrition-sensitive agriculture programme in Burkina Faso. Matern Child Nutr. 2018 Jul;14(3):e12573. doi: 10.1111/mcn.12573. Epub 2017 Dec 26.
PubMed 29278449Olney DK, Bliznashka L, Pedehombga A, Dillon A, Ruel MT, Heckert J. A 2-Year Integrated Agriculture and Nutrition Program Targeted to Mothers of Young Children in Burkina Faso Reduces Underweight among Mothers and Increases Their Empowerment: A Cluster-Randomized Controlled Trial. J Nutr. 2016 May;146(5):1109-17. doi: 10.3945/jn.115.224261. Epub 2016 Apr 13.
PubMed 27075910Olney DK, Pedehombga A, Ruel MT, Dillon A. A 2-year integrated agriculture and nutrition and health behavior change communication program targeted to women in Burkina Faso reduces anemia, wasting, and diarrhea in children 3-12.9 months of age at baseline: a cluster-randomized controlled trial. J Nutr. 2015 Jun;145(6):1317-24. doi: 10.3945/jn.114.203539. Epub 2015 Apr 22.
PubMed 25904734
Study at a glance
From the registry record, last updated by the sponsor on 1 May 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- THE IMPACT OF THE ENHANCED HOMESTEAD FOOD PRODUCTION PROGRAM ON CHILD HEALTH
- ClinicalTrials.gov ID
- NCT01825226
- Acronym / sponsor ID
- EHFP / 6117001
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 1,763 participants (actual)
- Lead sponsor
- International Food Policy Research InstituteUniversity, hospital or other
- Collaborators
- United States Agency for International Development (USAID), Bill and Melinda Gates Foundation
- Study start
- Feb 2010
- Primary completion
- Jun 2013 (actual)
- Study completion
- 28 Sep 2016 (actual)
- First posted
- 5 Apr 2013 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Helen Keller International (HKI) has been implementing homestead food production (HFP) programs in Asia for the past 20 years and has recently begun implementing HFP programs in Africa as well. In general, these programs target women and are designed to improve maternal and child health and nutrition outcomes through three primary pathways: 1. Increasing the availability of micronutrient-rich foods through increased household production of these foods; 2. Raising income through the sale of surplus production; and 3. Increasing knowledge and adoption of optimal nutrition practices, including the consumption of micronutrient-rich foods. Evaluations of HFP programs have consistently demonstrated significant increases in household production and consumption of micronutrient-rich foods. This increased consumption, along with improvements in health and nutrition related knowledge, and increased income, could all contribute to improvements in maternal and child health and nutrition outcomes. However, to date there has been limited understanding as to how these types of programs can be optimized to maximize impacts on these outcomes.
In order to better understand the potential of these types of programs to improve maternal and child health and nutrition outcomes and how this impact may be achieved IFPRI has been collaborating with HKI to evaluate one of their E-HFP programs in Burkina Faso. The evaluation considers impact of the program through the three pathways above, and assesses anthropometric and clinical measures of nutrition, as well as looking at how the programs might be improved.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Program participation | Experimental | Other: Enhanced-Homestead Food Production ProgramParticipation in an enhanced-homestead food production program including home gardening and nutrition and health behavior change communication |
| Control | No intervention | – |
Who may qualify
- Ages
- 3 to 12 months
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child
Key inclusion criteria (1 listed)
- Mother of child between the ages of 3 and 12 months and her child
Key exclusion criteria (1 listed)
- N/A
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Enhanced-Homestead Food Production ProgramParticipation in an enhanced-homestead food production program including home gardening and nutrition and health behavior change communication | Other | Program participation |
Primary outcome
Growth
Time frame: Measurements will be made for children between the ages of 3 and 12 months of age at baseline and then 2 years later, at endline, when the children are between the ages of 23 and 40 months
Change in height-for-age Z-scores, weight-for-age Z-scores and weight-for-height Z-scores will be measured as well as the change in the prevalence of stunting (HAZ <-2), underweight (WAZ <-2) and wasting (WHZ <-2) over the course of the two year program period.
Hemoglobin
Time frame: Measurements will be made for children between the ages of 3 and 12 months of age at baseline and then 2 years later, at endline, when the children are between the ages of 23 and 40 months
8 secondary outcomes
Food security
Time frame: Baseline (2010), Endline (2012), follow-up (2013)
Household assets
Time frame: Baseline (2010), Endline (2012), follow-up (2013)
Household consumption
Time frame: Baseline (2010), Endline (2012), follow-up (2013)
Household livestock holdings
Time frame: Baseline (2010), Endline (2012), follow-up (2013)
Dietary diversity
Time frame: Baseline (2010), Endline (2012), follow-up (2013)
Mother's BMI
Time frame: Baseline (2010), Endline (2012), follow-up (2013)
Maternal health and nutrition-related knowledge
Time frame: Baseline (2010), Endline (2012), follow-up (2013)
IYCF practices
Time frame: Baseline (2010), Endline (2012), follow-up (2013)
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 1 May 2025.
- Derived from this study: PubMed 29278449Nielsen JN, Olney DK, Ouedraogo M, Pedehombga A, Rouamba H, Yago-Wienne F. Process evaluation improves delivery of a nutrition-sensitive agriculture programme in Burkina Faso. Matern Child Nutr. 2018 Jul;14(3):e12573. doi: 10.1111/mcn.12573. Epub 2017 Dec 26.
- Derived from this study: PubMed 27075910Olney DK, Bliznashka L, Pedehombga A, Dillon A, Ruel MT, Heckert J. A 2-Year Integrated Agriculture and Nutrition Program Targeted to Mothers of Young Children in Burkina Faso Reduces Underweight among Mothers and Increases Their Empowerment: A Cluster-Randomized Controlled Trial. J Nutr. 2016 May;146(5):1109-17. doi: 10.3945/jn.115.224261. Epub 2016 Apr 13.
- Derived from this study: PubMed 25904734Olney DK, Pedehombga A, Ruel MT, Dillon A. A 2-year integrated agriculture and nutrition and health behavior change communication program targeted to women in Burkina Faso reduces anemia, wasting, and diarrhea in children 3-12.9 months of age at baseline: a cluster-randomized controlled trial. J Nutr. 2015 Jun;145(6):1317-24. doi: 10.3945/jn.114.203539. Epub 2015 Apr 22.
Related trials for Growth
Recruiting
Short-Term Reduced Dietary Protein in ER+/HER2- Breast Cancer Patients During Neoadjuvant Chemotherapy
Breast Cancer, Hormone Receptor Positive / HER2-negative Breast Cancer
RecruitingPhase 3
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8
RecruitingPhase 2
Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03)
Breast Neoplasms, Breast Cancer
RecruitingPhase 1/2
A Study of VRN110755 in Patients With EGFR-Mutant Non-Small Cell Lung Cancer
EGFR-Mutant Non-Small Cell Lung Cancer
Active, not recruitingPhase 2
Safety, Preliminary Effectiveness of BNT327, an Investigational Therapy for Patients With Small-cell Lung Cancer in Combination With Chemotherapy
Extensive-stage Small-cell Lung Cancer, Small-cell Lung Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Deanna K Olney, Ph.D. principal investigator
International Food Policy Research Institute
Andrew Dillon, Ph.D. principal investigator
Michigan Sate University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Enhanced-Homestead Food Production Program in people with Growth and Anemia, run by International Food Policy Research Institute at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 1 May 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Growth (time frame: Measurements will be made for children between the ages of 3 and 12 months of age at baseline and then 2 years later, at endline, when the children are between the ages of 23 and 40 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT01825226, which also lists 3 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 May 2025.